688596 Shanghai Gentech
- 34.06
- -0.42-1.22%
Shanghai Gentech News
Express News | This week, 30 A-shares listed companies disclosed the latest announcements on mergers and acquisitions. Guosen intends to purchase 96.08% shares of Wanhua Securities for 5.192 billion yuan.
Shanghai Gentech (688596): Acquiring Hongge Equity Consolidates Component Layout, Normalized Incentives Promote Long-Term Development
Event Overview: On December 3, the company consecutively announced three important matters: the acquisition of Hongge's shares, the second phase of the employee stock ownership plan, and the issuance of convertible bonds. The global strategy is clear, the business development logic is straightforward, and the long-term development prospects are bright.
Shanghai Gentech (688596.SH) plans to acquire 30.5032% equity of its subsidiary, Hongge Semiconductor, for 0.336 billion yuan.
Shanghai Gentech (688596.SH) announced that, based on the controlling subsidiary Honghe Semiconductor Equipment (shanghai) limited ...
Shanghai Gentech (688596.SH): Plans to launch the second phase of the employee stock ownership plan.
On December 3, Gelonghui announced that Shanghai Gentech (688596.SH) has released the second phase of its employee stock ownership plan, which involves a maximum of 6,104,603 stocks, accounting for approximately 2.11% of the total company's equity (calculated based on the total shares of 289,162,626 as of November 30, 2024). The total number of employees participating in this employee stock ownership plan will not exceed 70, including 2 directors (excluding independent directors) and senior management personnel; the exact number of participants will be determined based on actual circumstances.
Express News | Shanghai Gentech: intends to acquire 30.5032% equity of Hongge Semiconductors for 0.336 billion yuan.
shanghai gentech (688596): Performance meets expectations. Significant progress in OPEX business.
Core viewpoint: Performance meets expectations. The company published its third quarter report on October 30, achieving revenue of 3.501 billion yuan in Q1-3 of 2024, +45.23% year-on-year, with net income of 0.332 billion yuan, +22.58% year-on-year.
shanghai gentech (688596): In the third quarter of 2024, revenue performance continued to grow significantly, issuing convertible bonds to increase production capacity for electronic materials and pharmaceutical equipment.
Performance Brief The company disclosed its third quarter report for 2024 on October 31, 2024. In 3Q24, the company achieved revenue of 3.501 billion yuan, a year-on-year increase of +45.23%; achieving a net income attributable to the parent of 0.332 billion yuan, year-on-year
Zhengfan Technology: Report of Shanghai Zhengfan Technology Co., Ltd. Third Quarter 2024
Shanghai Zhengfan Technology Co., Ltd. Report for the Third Quarter of 2024
shanghai gentech (688596): Starting from high-purity process media system, layout of multi-grid products and application fields.
The core point of view is that the company continues to expand its products around the broad semiconductors, biomedical, and other homologous customers, expanding from process medium systems, MRO to GAS BOX, gases, advanced materials, and from CAPEX to OPEX business.
Zhengfan Technology: Voluntary Disclosure Notice of Shanghai Zhengfan Technology Co., Ltd. on the performance forecast for the first three quarters of 2024
Voluntary disclosure announcement of Shanghai Zhengfan Technology Co., Ltd. on the results forecast for the first three quarters of 2024
Express News | Shanghai Gentech: The net income for the first three quarters of 2024 is expected to grow by 20% to 25%.
shanghai gentech (688596) 2024 third quarter performance forecast: Q3 performance exceeds market expectations, OPEX continues to realize growth logic.
Event Overview Shanghai Gentech released the 2024 third quarter performance forecast. The pace of confirmed orders is accelerating, with Q3 revenue performing better than market expectations. The company is expected to achieve a revenue of 338-361 billion yuan in 2024 Q1-3, a year-on-year +
Express News | Shanghai Gentech: The "Suzhou Huaye Gas Manufacturing Co., Ltd. Phase I Technical Renovation Project" is officially put into operation.
Shanghai Gentech (688596): Order fulfillment, continuous strength in three major business sectors.
Investment Highlights: On August 30, Shanghai Gentech released the 2024 interim report. In the first half of 2024, the company achieved revenue of 1.852 billion yuan, a year-on-year increase of 37.78%; net income attributable to the parent company was 0.105 billion yuan, the same
Shanghai Gentech (688596): Full order backlog, 1H24 non-GAAP net income attributable to parent company maintains high growth.
The company disclosed its 2024 interim report on August 29, achieving a revenue of 1.852 billion yuan in the first half of 2024, a year-on-year increase of 37.78%; achieving a net income attributable to the parent company of 0.105 billion yuan, a year-on-year decrease of 29.94%.
Shanghai Zhengfan Technology Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Shanghai Zhengfan Technology Co., Ltd.
Shanghai Gentech (688596.SH) released its semi-annual performance, with net income of 0.105 billion yuan, a year-on-year decrease of 29.94%.
shanghai gentech (688596.SH) disclosed its 2024 interim report, reporting that the company achieved revenue of 18.5...
No Data
